HCM
RDY icon

Highbridge Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Highbridge Capital Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-150,000
Closed -$1.07M – 1904
2017
Q3 		$1.07M Buy
+150,000
New +$1.08M 0.02% 570

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Highbridge Capital Management's RDY Position: Q4 2017 in Review

Highbridge Capital Management sold out of Dr. Reddy's Laboratories (RDY) in Q4 2017, closing a stake of 150,000 shares — an estimated $1.07M sold.

Highbridge Capital Management first reported a position in RDY in Q3 2017 and held it in 1 quarter. The position peaked at $1.07M in Q3 2017. 118 funds tracked by Wall St. Rank hold RDY as of Q4 2017.

  • Highbridge Capital Management reported no remaining Dr. Reddy's Laboratories position as of Q4 2017 after selling out during the quarter.
  • Highbridge Capital Management sold 150,000 Dr. Reddy's Laboratories shares in Q4 2017, an estimated $1.07M.
  • Highbridge Capital Management first reported a position in Dr. Reddy's Laboratories in Q3 2017 and held it in 1 quarter.
  • Highbridge Capital Management's Dr. Reddy's Laboratories position peaked at $1.07M in Q3 2017.
  • 118 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2017.

Based on Highbridge Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.